Organigram Global (OGI) Shares Outstanding (2018 - 2026)

Organigram Global (OGI) posted quarterly Shares Outstanding (Entity) of $97.7 million for Q3 2025, up 22.75% year-on-year from $79.6 million in Q3 2024, and up 8.19% on a QoQ basis from $90.3 million in Q4 2024.

Organigram Global (OGI) Shares Outstanding (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Shares Outstanding (Entity) for 8 consecutive years, with $97.7 million the latest figure, recorded in Q3 2025.

  • Quarterly Shares Outstanding (Entity) rose 22.75% year-over-year to $97.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $97.7 million (up 22.75% YoY) and the FY2025 annual result came in at $97.7 million, up 22.75% from the prior year.
  • Shares Outstanding (Entity) grew to $97.7 million in Q3 2025 per OGI's latest filing, from $90.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for OGI reached as high as $736.9 million in Q2 2021 and fell as low as $60.1 million in Q3 2021.
  • A 5-year average of $186.6 million and a median of $85.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) jumped 2101.77% — and 2022, when it climbed 1.38%.
  • Year by year, Shares Outstanding (Entity) stood at $306.7 million in 2021, then sank by 80.14% to $60.9 million in 2022, then slipped by 0.62% to $60.5 million in 2023, then jumped by 49.17% to $90.3 million in 2024, then rose by 8.19% to $97.7 million in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $97.7 million, $90.3 million, and $79.6 million for Q3 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 8.98 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.16 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 422.10 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 43.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 455,871.00
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 100.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 497.70 Mn
10 Organigram Global 89.89 Mn 122.96 Mn 28.97 Mn 127.67 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 127.67 Mn
Dec 31, 2025 127.67 Mn
Sep 30, 2025 127.67 Mn
Mar 31, 2025 95.29 Mn
Dec 31, 2024 95.29 Mn
Sep 30, 2024 95.29 Mn
Sep 30, 2023 81.29 Mn
Aug 31, 2022 77.23 Mn
Nov 30, 2021 306.70 Mn
Aug 31, 2021 64.03 Mn
May 31, 2021 736.87 Mn
Feb 28, 2021 606.98 Mn
Nov 30, 2020 50.50 Mn
Aug 31, 2020 43.17 Mn
May 31, 2020 43.84 Mn
Feb 29, 2020 1.24 Bn
Nov 25, 2019 35.23 Mn
Aug 31, 2019 35.23 Mn
May 31, 2019 37.44 Mn
Feb 28, 2019 86.25 Mn